Itama Ranoraya (JK:IRRA) — Market Cap & Net Worth
Market Cap & Net Worth: Itama Ranoraya (IRRA)
Itama Ranoraya (JK:IRRA) has a market capitalization of $32.69 Million (Rp557.89 Billion) as of September 16, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #23560 globally and #483 in its home market, demonstrating a -1.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Itama Ranoraya's stock price Rp370.00 by its total outstanding shares 1507817400 (1.51 Billion). Also see IRRA total assets for a full breakdown of the balance sheet.
Itama Ranoraya Market Cap History: 2019 to 2026
Itama Ranoraya's market capitalization history from 2019 to 2026. Data shows change from $55.55 Million to $32.69 Million (-5.36% CAGR). Also see Itama Ranoraya operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Itama Ranoraya is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$512.20 Billion | 0.01% | #472 of 864 |
Weight: Itama Ranoraya's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Itama Ranoraya Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Itama Ranoraya's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Itama Ranoraya (IRRA) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Itama Ranoraya's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Itama Ranoraya's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $55.55 Million | $281.75 Billion | $33.21 Billion | 0.00x | 0.00x |
| 2020 | $138.31 Million | $563.89 Billion | $60.52 Billion | 0.00x | 0.00x |
| 2021 | $171.94 Million | $1.32 Trillion | $112.16 Billion | 0.00x | 0.00x |
| 2022 | $95.42 Million | $753.57 Billion | $48.00 Billion | 0.00x | 0.00x |
| 2023 | $70.68 Million | $696.30 Billion | $5.20 Billion | 0.00x | 0.01x |
| 2024 | $35.34 Million | $977.49 Billion | $53.26 Billion | 0.00x | 0.00x |
Competitor Companies of IRRA by Market Capitalization
Companies near Itama Ranoraya in the global market cap rankings as of September 16, 2026. Review Itama Ranoraya tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Itama Ranoraya by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #250 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #544 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #644 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1213 globally with a market cap of $21.48 Billion USD ( AU$30.36 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #250 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $910.95 |
| #544 | Cencora Inc. | NYSE:COR | $50.53 Billion | $326.23 |
| #644 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $234.89 |
| #1213 | Sigma Healthcare Ltd | AU:SIG | $21.48 Billion | AU$2.63 |
Itama Ranoraya Historical Marketcap From 2019 to 2026
Between 2019 and today, Itama Ranoraya's market cap moved from $55.55 Million to $ 32.69 Million, with a yearly change of -5.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp32.69 Million | -12.74% |
| 2025 | Rp37.46 Million | +6.00% |
| 2024 | Rp35.34 Million | -50.00% |
| 2023 | Rp70.68 Million | -25.93% |
| 2022 | Rp95.42 Million | -44.50% |
| 2021 | Rp171.94 Million | +24.32% |
| 2020 | Rp138.31 Million | +148.97% |
| 2019 | Rp55.55 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of Itama Ranoraya was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.69 Million USD |
| MoneyControl | $32.69 Million USD |
| MarketWatch | $32.69 Million USD |
| marketcap.company | $32.69 Million USD |
| Reuters | $32.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more